Valsartan combined with clopidogrel and/or leflunomide for the treatment of progressive immunoglobulin A nephropathy (pages 77–84)
Genyang Cheng, Dongwei Liu, Peter Margetts, Limin Liu, Zhanzheng Zhao, Zhangsuo Liu, Lin Tang, Yudong Fang, Haijian Li, Yuanyuan Guo, Fengmei Chen and Fengxun Liu
Article first published online: 24 JAN 2015 | DOI: 10.1111/nep.12359
Summary at a Glance
In this randomized clinical trial, patients with IgA nephropathy at moderate risk of progression showed a greater degree of proteinuria reduction and GFR preservation with leflunimide and clopidogrel.